Simvastatin alleviates inflammatory bone resorption by modulating mitophagy pathway in osteoblasts
碩士 === 國立臺灣大學 === 臨床牙醫學研究所 === 102 === Mitochondria are the organelles that deal with hypoxia, a potential therapeutic target for the treatment of inflammatory diseases. Through mitophagy, a process of mitochondrial degradation by autophagy, cells rid themselves of dysfunctional components to mainta...
Main Authors: | Wan-Yu Lu, 盧宛瑜 |
---|---|
Other Authors: | Sze-Kwan Lin |
Format: | Others |
Language: | zh-TW |
Published: |
2014
|
Online Access: | http://ndltd.ncl.edu.tw/handle/11814630811560512772 |
Similar Items
-
Metformin alleviates inflammatory bone resorption by modulating apoptosis in osteoblasts
by: I-Hsuan Su, et al.
Published: (2017) -
Increased Osteoblastic Cxcl9 Contributes to the Uncoupled Bone Formation and Resorption in Postmenopausal Osteoporosis
by: Liu Z, et al.
Published: (2020-07-01) -
Peptidomimetic inhibitors of L-plastin reduce the resorptive activity of osteoclast but not the bone forming activity of osteoblasts in vitro.
by: Meenakshi A Chellaiah, et al.
Published: (2018-01-01) -
Osteoblast–Osteoclast Coculture Amplifies Inhibitory Effects of FG‐4592 on Human Osteoclastogenesis and Reduces Bone Resorption
by: Philippa A Hulley, et al.
Published: (2020-07-01) -
Intrinsic Restriction of TNF-Mediated Inflammatory Osteoclastogenesis and Bone Resorption
by: Baohong Zhao, et al.
Published: (2020-10-01)